Scientific Publications


May 18th, 2018

NATIVE ANTIGEN COMPANY BIBLIOGRAPHY At the Native Antigen Company we are proud of the quality of our products, and one of the ways in which this is best demonstrated is when our customers use our reagents in their published work. We have compiled a list of publications that we are aware of, which we have […]

NS1 based serological assay differentiates Zika from other Flavivirus infections

July 20th, 2017

Native Antigen Company Zika NS1 used in new publication A publication in PNAS (Balmaseda et al)  originating from Humabs and the University of Berkeley has demonstrated the ability to use Zika NS1 and an NS1 specific monoclonal antibody to develop a highly specific Zika NS1 serological assay test for Zika infection.    The high level […]

Specificity, cross-reactivity and function of antibodies elicited by Zika virus infection

August 22nd, 2016

A large collaboration between our friends at PHE and the Harris lab (amongst many others!) who have just published in Nature using our antigens to characterise various aspects of Zika virus in comparison to other flaviviruses. Yet more evidence that our antigens are of excellent use in diagnostics. Specificity, cross-reactivity and function of antibodies elicited […]

NAC Yellow Fever NS1 used in development of multiplex diagnostics

April 21st, 2016

An interesting paper from the Gehrke lab at the MIT, demonstrating the use of multi-colored silver nanoparticles in the development of a multiplex lateral flow assay for Dengue, Ebola and Yellow Fever detection, utilising Yellow Fever NS1 antigen from the Native Antigen Company.  This demonstrates the feasibility of preparing such devices to improve the rapid […]

“NS1 should be part of dengue vaccine”

October 27th, 2015

Well done to Robert, Eva and everyone at the Harris lab for their latest paper published in Science Translational Medicine. Using Native Antigen Company DENV NS1 products they have shown that anti-NS1 antibodies can protect against the pathogenic effects of NS1, and immunisation with NS1 can protect against a lethal DENV 2 challenge. This supports […]

New publication using NAC NS1

July 2nd, 2015

We’d like to congratulate Tesfaye and her colleagues at the CDC for an excellent paper in Journal of Virological methods, using Native Antigen Company DENV, YFV and WNV NS1 products to characterise their new monoclonals. Development and characterization of mouse monoclonal antibodies against monomeric dengue virus non-structural glycoprotein 1 (NS1). Gelanew T, Poole-Smith BK, Hunsperger […]